LakeShore Biopharma Co., Ltd (LSBCF)
OTCMKTS · Delayed Price · Currency is USD
0.0310
0.00 (0.00%)
At close: Apr 10, 2026
LakeShore Biopharma Revenue
In the fiscal year ending March 31, 2025, LakeShore Biopharma had annual revenue of 614.96M CNY with 7.24% growth. LakeShore Biopharma had revenue of 135.35M in the quarter ending March 31, 2024, with 27.67% growth.
Revenue
614.96M CNY
Revenue Growth
-6.54%
P/S Ratio
0.02
Revenue / Employee
1.07M CNY
Employees
573
Market Cap
1.28M USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 614.96M | 41.54M | 7.24% |
| Mar 31, 2024 | 573.42M | -113.78M | -16.56% |
| Mar 31, 2023 | 687.20M | 184.25M | 36.63% |
| Mar 31, 2022 | 502.95M | 245.93M | 95.69% |
| Mar 31, 2021 | 257.02M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CASI Pharmaceuticals | 26.85M |
| Vaccinex | 601.00K |
| GPL Holdings | 376.54K |
| AXIM Biotechnologies | 92.90K |
| Enzolytics | 46.59K |
| Oncology Pharma | 10.21K |
LakeShore Biopharma News
- 17 days ago - LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company - PRNewsWire
- 2 months ago - LakeShore Biopharma Announces Receipt of Buyer Group Notice and Postponement of Extraordinary General Meeting of Shareholders - PRNewsWire
- 2 months ago - LakeShore Biopharma to Hold Extraordinary General Meeting of Shareholders - PRNewsWire
- 5 months ago - LakeShore Biopharma Enters into Definitive Agreement for Going-Private Transaction - PRNewsWire
- 7 months ago - LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting - PRNewsWire
- 7 months ago - LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq - PRNewsWire
- 7 months ago - LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee - PRNewsWire
- 8 months ago - LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee - PRNewsWire